Dihydrospiroindene modulators of muscarinic receptors
The present invention relates to dihydrospiroindene modulators of muscarinic receptors. The present invention also provides compositions comprising such dihydrospiroindene modulators, and methods therewith for treating muscarinic receptor mediated diseases.
1. A compound selected from:
483
487
490
521
525
533
536
542
546
566
586
599
609
612
638
641
643
650
609
713
715
725
732
755
758
759
779
787
801
830
834
842
863
865
867
868
876
901
904
919
922
960
979
983
1002
1005
1017
2. A pharmaceutical composition comprising a compound selected from:
483
487
490
521
525
533
536
542
546
566
586
599
609
612
638
641
643
650
609
713
715
725
732
755
758
759
779
787
801
830
834
842
863
865
867
868
876
901
904
917
922
960
979
983
1002
1005
1017
and a pharmaceutical carrier.